By Stewart Eisenhart, Emergo Group
New guidance from Health Canada would establish cybersecurity requirements and considerations for pre-market reviews of devices in Canada similar to policies developed by US and South Korean regulators.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.